feed,title,long_url,short_url
SeekingAlpha,Immunic stock gains 6% on FDA go ahead for IMU-838 trials in multiple sclerosis,https://seekingalpha.com/news/3711708,
SeekingAlpha,Turkish e-commerce platform Hepsiburada prices initial public offering at $12/ADS,https://seekingalpha.com/news/3711709,
